Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss-Reference-Cited by-同舟云学术

Successful MDR-TB treatment regimens including Amikacin are associated with high rates of hearing loss

Published:2014-10-09 Issue:1 Volume:14 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Modongo Chawangwa,Sobota Rafal S,Kesenogile Boikobo,Ncube Ronald,Sirugo Giorgio,Williams Scott M,Zetola Nicola M

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/1471-2334-14-542.pdf

Reference44 articles.

1. Caminero JA: Guidelines for the Clinical and Operational Management of Drug-Resistant Tuberculosis. 2013, 68 boulevard St Michel, 75006 Paris, Franc: International Union Against Tuberculosis and Lung Disease (The Union)

2. Organization WH: Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. 2011, Geneva: WHO/HTM/TB/2011.6

3. Health FJCNTCaCDoP: Drug-Resistant Tuberculosis: A Survival Guide for Clinicians. 2008, 2

4. World Health O: Multidrug-resistant tuberculosis (MDR-TB) October 2013 Update. 2013

5. Program BNT: National Tuberculosis Manual. 2011, Ministry of Health: Gaborone, 7

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ISCCM Position Statement on the Approach to and Management of Critically Ill Patients with Tuberculosis;Indian Journal of Critical Care Medicine;2024-08-10

2. Establishing multifactorial risk factors for adult-onset hearing loss: A systematic review with topic modelling and synthesis of epidemiological evidence;Preventive Medicine;2024-01

3. Understanding Hearing Impairments;Handbook of Research on Shifting Paradigms of Disabilities in the Schooling System;2023-10-16

4. Hearing assessment and treatment outcome in ENT tuberculosis at a tertiary hospital in India;The Egyptian Journal of Otolaryngology;2023-10-06

5. Prevalence and factors associated with reported adverse-events among patients on multi-drug-resistant tuberculosis treatment in two referral hospitals in Uganda;BMC Infectious Diseases;2023-03-10